Mandarin Drugs Private Limited
About Mandarin Drugs Private Limited
Data last updated:
Mandarin Drugs Private Limited is a private limited company based in Meerut, Uttar Pradesh, India. It operates in the retail trade segment of the trading and commerce sector. It was incorporated on 04 December 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U36912UP2015PTC074847.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Tanya Verma and Ashok Kumar Verma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 102/2 Sant Vihar T.P. Nagar, Meerut, Uttar Pradesh, India – 250002.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mandarin Drugs Private Limited's registered office is in Meerut, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 102/2 Sant Vihar T.P. Nagar, Meerut, Uttar Pradesh, India – 250002
- IndustryTrading, Retailers, Retail Trading
To see the full contact details of Mandarin Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mandarin Drugs is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Mandarin Drugs Private Limited, buy the company report.
Financials of Mandarin Drugs Private Limited
FY 2025 filings availableMandarin Drugs Private Limited reported revenue of ₹9,550 for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mandarin Drugs Private Limited, buy the company report.
Board of directors of Mandarin Drugs Private Limited
Mandarin Drugs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tanya Verma | Director | 16 Aug 2017 | 9 Years 2 Months | Current |
| Ashok Kumar Verma | Director | 04 Dec 2015 | 10 Years 11 Months | Current |
Peer comparison
Mandarin Drugs Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Abmi Consultants Limited | ₹9,600 (FY 2024) | 188.0% | Kolkata, West Bengal, India | |||
| Cygnus Dealers Private Limited | ₹9,600 (FY 2024) | -4.0% | Kolkata, West Bengal, India | |||
| Antarisk Agro Agencies Limited | ₹9,600 (FY 2024) | 106.0% | Howrah, West Bengal, India | |||
| Petvishwa Private Limited | ₹9,600 (FY 2023) | Pune, Maharashtra, India | ||||
| Abd Visava Overseas Private Limited | ₹9,571 (FY 2024) | -96.0% | Indore, Madhya Pradesh, India | |||
| Mandarin Drugs Private Limitedthis company | ₹9,550 (FY 2024) | Meerut, Uttar Pradesh, India | ||||
| Panchwati Vinimay Private Limited | ₹9,539 (FY 2025) | -97.0% | Ferozepur, Punjab, India | |||
| Vajra Tech Innovations Private Limited | ₹9,538 (FY 2024) | -83.0% | Bangalore, Karnataka, India | |||
| Coolhut Developers Private Limited | ₹9,530 (FY 2025) | -68.0% | Kolkata, West Bengal, India | |||
| Alokik Fashions Private Limited | ₹9,524 (FY 2024) | 154.0% | Gurgaon, Haryana, India | |||
| Newage Corro Inhibitors P Ltd | ₹9,520 (FY 2025) | -96.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Mandarin Drugs Private Limited, buy the company report.
Auditor
Mandarin Drugs Private Limited is audited by RAHUL PURUSHOTAM & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAHUL PURUSHOTAM & CO. | FY 2017 | 417574 |
Shareholding
The shareholding of Mandarin Drugs Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Mandarin Drugs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mandarin Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mandarin Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Mandarin Drugs Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mandarin Drugs Private Limited has 3 board changes on record since 2015: 2 appointments and 1 cessation. The latest: Sandip Kumar Gupta ceased to be Director on 16 Aug 2017.
Frequently asked questions
Mandarin Drugs is an active private limited company based in Meerut, Uttar Pradesh, India. The company works in retailers, within the trading industry. It was incorporated on 04 December 2015 (11+ years old) and is registered under CIN U36912UP2015PTC074847.
Mandarin Drugs has 2 current directors:
- Tanya Verma - Director
- Ashok Kumar Verma - Director
The latest financial statements of Mandarin Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The CIN (Corporate Identification Number) of Mandarin Drugs is U36912UP2015PTC074847. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mandarin Drugs was incorporated on 04 December 2015, making it 11+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Mandarin Drugs by revenue are Abmi Consultants Limited, Cygnus Dealers Private Limited, Antarisk Agro Agencies Limited, Petvishwa Private Limited, Abd Visava Overseas Private Limited and 5 more, all in the same principal business activity (retail trading).
Sandip Kumar Gupta ceased to be Director on 16 Aug 2017. Tanya Verma was appointed as Director on 16 Aug 2017. Ashok Kumar Verma was appointed as Director on 04 Dec 2015.
The registered office of Mandarin Drugs is at A – 1022 Sant Vihar T.P. Nagar, Meerut, Uttar Pradesh, India – 250002.
Mandarin Drugs operates in the trading industry, in the retailers segment.
The compliance status of Mandarin Drugs is compliant as of 02 July 2026. The company is actively filing with the Registrar of Companies.
Mandarin Drugs can be reached at its registered office: A – 1022 Sant Vihar T.P. Nagar, Meerut, Uttar Pradesh, India – 250002.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
